Premium Deep Dive Krystal Biotech Deep Dive: January 2022 Jan 1, 2022 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 2022 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2022 is developing a novel technology platform that's well-positioned to address some of the biggest challenges facing gene therapy... Jan 1, 2022 - By Maxx Chatsko Biotechnology Article Dicerna Pharmaceuticals Deep Dive: October 2021 For the first time ever, we are releasing an active recommendation to the general public as three-time recommendation Dicerna Pharmaceuticals was acquired by Novo Nordisk in a $3.3 billion deal. Dec 28, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Disrupt Cell Therapy? Dec 20, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: December 2021 Dec 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in December 2021 has just de-risked the entire therapeutic modality of gene therapy -- and Wall Street is entirely misunderstanding the... Dec 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update I Choose Embarrassment Nov 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for January 2022 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2022 is developing a novel technology platform that's well-positioned to address some of the biggest challenges facing gene therapy... Jan 1, 2022 - By Maxx Chatsko Biotechnology Article Dicerna Pharmaceuticals Deep Dive: October 2021 For the first time ever, we are releasing an active recommendation to the general public as three-time recommendation Dicerna Pharmaceuticals was acquired by Novo Nordisk in a $3.3 billion deal. Dec 28, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Disrupt Cell Therapy? Dec 20, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: December 2021 Dec 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in December 2021 has just de-risked the entire therapeutic modality of gene therapy -- and Wall Street is entirely misunderstanding the... Dec 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update I Choose Embarrassment Nov 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Dicerna Pharmaceuticals Deep Dive: October 2021 For the first time ever, we are releasing an active recommendation to the general public as three-time recommendation Dicerna Pharmaceuticals was acquired by Novo Nordisk in a $3.3 billion deal. Dec 28, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Disrupt Cell Therapy? Dec 20, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: December 2021 Dec 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in December 2021 has just de-risked the entire therapeutic modality of gene therapy -- and Wall Street is entirely misunderstanding the... Dec 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update I Choose Embarrassment Nov 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Can Better Antibodies Disrupt Cell Therapy? Dec 20, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: December 2021 Dec 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in December 2021 has just de-risked the entire therapeutic modality of gene therapy -- and Wall Street is entirely misunderstanding the... Dec 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update I Choose Embarrassment Nov 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Selecta Biosciences Deep Dive: December 2021 Dec 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in December 2021 has just de-risked the entire therapeutic modality of gene therapy -- and Wall Street is entirely misunderstanding the... Dec 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update I Choose Embarrassment Nov 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for December 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in December 2021 has just de-risked the entire therapeutic modality of gene therapy -- and Wall Street is entirely misunderstanding the... Dec 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update I Choose Embarrassment Nov 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update I Choose Embarrassment Nov 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Coherus BioSciences Deep Dive: November 2021 Nov 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for November 2021 7investing Lead Advisor Maxx Chatsko's top stock to buy in November 2021 is at the very beginning of an inflection point in its growth trajectory. Nov 1, 2021 - By Maxx Chatsko Biotechnology Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Navigating Inflation and Interest Rates with Your Hard-Earned Money Even long-term investors should acknowledge the role that Fed policy is playing in stock valuations. Oct 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Supplement Your Approach to Health and Investing with A Dose… Oct 14, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Drug Development is Risky. Let’s Count the Ways. Oct 14, 2021 - By Maxx Chatsko Biotechnology Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Can Your Gene Editing Stocks Survive the End of Momentum? There are both opportunities and challenges to modifying DNA for therapeutic applications, but objective information is scarce. Oct 8, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: October 2021 Oct 1, 2021 - By Maxx Chatsko Biotechnology Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Why are $100 Billion Drug Developers Such Lousy Investments? While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after. Sep 23, 2021 - By Maxx Chatsko Biotechnology Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Give Your Thesis Time to Breathe, But Be Objective Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader. Sep 22, 2021 - By Maxx Chatsko Biotechnology Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article What’s Next for mRNA? The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas? Sep 15, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Swimming With Sharks When There’s Blood in the Water Sep 15, 2021 - By Dana Abramovitz Biotechnology Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Annual 2021 Review: Maxx’s 7investing Recommendations Sep 14, 2021 - By Maxx Chatsko Biotechnology Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Repligen Always Seems to Make the Right Moves The bioprocess leader quietly keeps delivering for shareholders. Aug 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update What Defines a Stock Market Bubble? Aug 13, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update The Psychedelics Trip Comes Full Circle May 14, 2021 - By Dana Abramovitz Biotechnology Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Are Psychedelics the Future of Neuroscience? Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks. Apr 27, 2021 - By 7investing Team Biotechnology Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Welcome Dana Abramovitz to 7investing! 7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care. Apr 12, 2021 - By 7investing Team Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive BiomX Deep Dive: March 2021 Mar 1, 2021 - By 7investing Team Biotechnology Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Manisha’s Top Stock for March 2021 Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform. Mar 1, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update The Alzheimer’s Saga Continues Feb 15, 2021 - By Manisha Samy Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update On the Future of DNA Sequencing Jan 15, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Intellia Deep Dive: January 2021 Jan 1, 2021 - By Manisha Samy Biotechnology Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Manisha’s Top Stock for January 7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases. Jan 1, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Gift Cards Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology
Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology
Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology
